Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Wayne Brinster Joins WHEATON® as President

Published: Friday, October 26, 2012
Last Updated: Friday, October 26, 2012
Bookmark and Share
The company will continue its focus on supporting laboratory research, and packaging for diagnostics and specialty pharmaceutical markets.

WHEATON has announced the appointment of Wayne Brinster to the role of president, succeeding Stephen R, Drozdow, who remains as chief executive officer.

Mr. Brinster brings to the position a familiar, science-driven focus while sharing Mr. Drozdow’s long-time commitment to WHEATON customers, suppliers, partners and employees.

Mr. Brinster comes to WHEATON from Synthon Pharmaceuticals, a privately owned manufacturer of pharmaceutical and biopharmaceutical products, where he served as vice president and general manager.

Prior to Synthon, Mr. Brinster worked in different management roles for over 30 years at Becton, Dickinson and Company, where he most recently led the BD Diagnostics Women’s Health and Cancer Care initiative.

“Having spent most of my life in the business of science, I am excited to be here with a leading name in the field, joining an organization that has developed a reputation for supporting important scientific achievements,” said Mr. Brinster.

“By leveraging technical knowledge with excellent customer service, we’re going to continue placing WHEATON at the forefront of the industry,” he added.

Mr. Drozdow, after leading WHEATON since 1996, will become the chief executive officer and will continue to have an active role at WHEATON, working closely with Mr. Brinster on matters pertaining to strategy, key industry relationships, finance, budgets and acquisitions. “Wayne is a great business leader,” said Mr. Drozdow. “He understands the science of our markets, knows our industry and identifies with our approach to customers.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Key Elements to Consider when Packaging Parenteral Products
Jeffrey Reid, Global Market Manager at WHEATON® discussed the critical processes of particulate cleaning, depyrogenation, and sterilization at the recent INTERPHEX event.
Wednesday, May 18, 2016
Wheaton Acquired By One Equity Partners
Acquisition will combine two of the world’s leading brands in laboratory consumables.
Thursday, September 17, 2015
WHEATON® Acquires Chromatography Vial Supply Company, MicroLiter
A specialty brand joins forces with an established industry leader resulting in an expanding product line and support services for the global HPLC market.
Friday, December 21, 2012
WHEATON® Announces Acquisition of CELLine™
WHEATON has acquired the CELLine bioreactor flask line for antibody and protein production from Wilson Wolf Manufacturing Corporation.
Tuesday, July 10, 2012
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!